Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?

Reducing the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is the key ultimate goal set in essentially all treatment guidelines. There has been solid evidence supporting the relationship between serum hepatitis B virus (HBV) DNA level and risk of HCC. Antivir...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gastroenterol
Hlavní autoři: Yip, Terry Cheuk-Fung, Lai, Jimmy Che-To, Wong, Grace Lai-Hung
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Singapore 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7567686/
https://ncbi.nlm.nih.gov/pubmed/32974760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-020-01726-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky